Paracetamol has often been cited as
a safer alternative to non-steroidal anti-inflammatory drugs (NSAIDs) with
regards blood pressure and cardiovascular health. But now researchers have
raised concerns about this, suggesting that those taking paracetamol long-term
may be at greater risk of heart attack and stroke.
Long-term paracetamol use could
increase the risk of heart disease and strokes in people with high blood
pressure, a study suggests.
Clinical trial
In the first large randomised
clinical trial to address whether paracetamol has an effect on blood pressure,
researchers from University of Edinburgh performed a double-blind,
placebo-controlled, cross-over study with 110 individuals, all of whom had hypertension.
In the latest study, all patients
with a history of high blood pressure were prescribed one gram of paracetamol
four times a day – a routinely prescribed dose in patients with chronic pain –
or a matched placebo for two weeks. All patients received both treatments, with
the order randomised and blinded.
Findings
In their study, published in
the scientific journal Circulation, the researchers found that
those prescribed paracetamol saw a significant increase in their systolic blood
pressure of around 5 mmHg, compared with those taking the placebo.
The rise in blood pressure was
similar to that seen with NSAIDs and might be expected to increase the risk of
heart disease or stroke by around 20%.
The research team says the findings
should lead to a review of long-term paracetamol prescriptions to patients –
particularly those with high blood pressure, or those at particular risk of
heart disease or stroke.
This study clearly shows that
paracetamol – the world’s most used drug – increases blood pressure, one of the
most important risk factors for heart attacks and strokes.
Suggestions for Clinicians
Doctors and patients together
should consider the risks versus the benefits of long-term paracetamol
prescription, especially in patients at risk of cardiovascular disease.
Researchers would recommend that
clinicians start with a low dose of paracetamol, and increase the dose in
stages, going no higher than needed to control pain.
Given the substantial rises in
blood pressure seen in some of the patients, there may be a benefit for
clinicians to keep a closer eye on blood pressure in people with high blood
pressure who newly start paracetamol for chronic pain.
Though further research in people with normal, healthy blood pressure, over a longer timeframe, was needed to confirm the risks and benefits of using paracetamol more widely.
Conclusion
This research shows how quickly
regular use of paracetamol can increase blood pressure in people with
hypertension who are already at increased risk of heart attacks and strokes. It
emphasises why doctors and patients should regularly review whether there is an
ongoing need to take any medication, even something that may seem relatively
harmless like paracetamol, and always weigh up the benefits and risks.
Background:
Paracetamol (acetaminophen) is
widely used as first-line therapy for chronic pain because of its perceived
safety and the assumption that, unlike nonsteroidal anti-inflammatory drugs, it
has little or no effect on blood pressure (BP). Although observational studies
suggest that paracetamol may increase BP, clinical trials are lacking. Researchers,
therefore, studied the effects of regular paracetamol dosing on BP in
individuals with hypertension.
Methods:
In this double-blind,
placebo-controlled, crossover study, 110 individuals were randomized to receive
1 g acetaminophen 4× daily or matched placebo for 2 weeks followed by a 2-week
washout period before crossing over to the alternate treatment. At the
beginning and end of each treatment period, 24-hour ambulatory BPs was
measured. The primary outcome was a comparison of the change in mean daytime
systolic BP from baseline to end of treatment between the placebo and paracetamol
arms.
Results:
One-hundred three patients
completed both arms of the study. Regular paracetamol, compared with placebo,
resulted in a significant increase in mean daytime systolic BP with a
placebo-corrected increase of 4.7 mm Hg and mean daytime diastolic BP with a
placebo-corrected increase of 1.6 mm Hg. Similar findings were seen for 24-hour
ambulatory and clinic BPs.
Conclusions:
Regular daily intake of 4 g
acetaminophen increases systolic BP in individuals with hypertension by ≈5
mm Hg when compared with placebo; this increases cardiovascular risk and calls
into question the safety of regular acetaminophen use in this situation.
Comments
You must login to write comment